References
[1]Del Prete G. The concept of type-1 and type-2 helper T cells and their cytokines in humans[J].Int Rev Immunol, 1998, 16(3-4): 427-455.
[2]Jancovic D, Liu Z, Gause WC. Th1-and Th2-cell commitment during infectious disease: asymmetry in divergent pathways[J].Trends Immunol, 2001, 22(8): 450-457.
[3]Qin W, Hongya W, Yongjing C, Fang X, Yue M, Xuekun Z, et al. Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura: association with renal involvement[J]. Pediatr Allergy Immunol, 2011, 22(1 Pt 1): 54-59.
[4]周承,王振开. 过敏性紫癜早期肾损害患儿T细胞亚群的变化及意义[J]. 实用临床医药杂志,2009,13(13): 96-98.
[5]陶红,李秋,王莉,李翠萃,阳海平,张高福. 过敏性紫癜发病中树突状细胞与T辅助细胞分化失衡的关系[J]. 第三军医大学学报, 2010, 32(7): 677-679.
[6]杨军,李成荣,祖莹,王国兵,李永柏. 调节性T细胞在儿童过敏性紫癜发病机制中的作用初探[J].中华儿科杂志, 2006, 44(6): 411-414.
[7]孙大庆, 张秋业, 董增义, 白枫. 过敏性紫癜病儿树突细胞分泌白细胞介素12水平与TH1/TH2的变化[J]. 中国当代儿科杂志, 2006, 8(4): 307-310.
[8]许自川,曾雪琪,党西强,何小解. Thl/Th2迁移与紫癜性肾炎的研究进展[J]. 国际病理科学与临床杂志, 2007, 27(1): 64-67.
[9]曾雪琪, 许自川, 党西强, 何小解, 易著文. 血管内皮生长因子与紫癜性肾炎肾间质微血管损伤的关系[J]. 中国当代儿科杂志, 2009, 11(9): 717-721.
[10]张建江,易著文,何小解,杨华彬,丁娟娟,莫双红. 紫癜性肾炎患儿肾间质血管损害与临床的关系[J].实用儿科临床杂志,2006,21(8):487-489.
[11]Kaneyama T, Kobayashi S, Aoyagi D, Ehara T. Tranilast modulates fibrosis, epithelial-mesenchymal transition and peritubular capillary injury in unilateral ureteral obstruction rats[J]. Pathology, 2010, 42(6): 564-573.
[12]Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of The microvascular endothelium in progressive renal disease[J]. J Am Soc Nephrol, 2002, 13(3): 806-816.
[13]Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, et al. Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice[J]. Am J Physiol Renal Physiol, 2007, 292(1): F261-F268.
[14]Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats[J]. J Am Soc Nephrol, 2000, 11(1): 47-56.
[15]中华医学会儿科学分会肾脏病学组.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志, 2001, 39(12):746-749.
[16]Mosmann TR, Coffman Rl. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties[J].Annu Rev Immunol, 1989, 7: 145-173.
[17]Yano T, Tanikawa S, Fujie T, Masutani M, Horie T. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer[J]. Eur J Cancer, 2000, 36(5): 601-609.
[18]Weidner N. Tumoural vascularity as a prognostic in cancer patients: the evidence continues to grow[J]. J Pathol, 1998, 184(2):119-122.
[19]吴杰,陈香美,师锁柱. 血管病变在1005例IgA肾病中的意义及其影响因素[J]. 中华医学杂志, 2003,83(4): 289-293.
[20]解德琼,甘华,杜晓刚,李正荣,巫江.终末期肾病患者Th1/Th2型细胞因子的特征与外周血T细胞凋亡的关系[J].细胞与分子免疫学杂志, 2006, 22(6):763-766.